2seventy bio to Participate in the 2024 Morgan Stanley Global Healthcare Conference
29 8월 2024 - 8:00PM
Business Wire
2seventy bio, Inc. (Nasdaq: TSVT), announced today that members
of the management team will participate in a fireside chat at the
upcoming Morgan Stanley 22nd Annual Global Healthcare Conference on
September 6, 2024 at 12:20 p.m. ET in New York.
A live webcast of the fireside chat will be available via the
Investors and Media section of the company’s website at
https://ir.2seventybio.com. Replays will be archived on the
2seventy bio website for 30 days following the events.
About 2seventy bio
Our name, 2seventy bio, reflects why we do what we do - TIME.
Cancer rips time away, and our goal is to work at the maximum speed
of translating human thought into action – 270 miles per hour – to
give the people we serve more time. With a deep understanding of
the human body’s immune response to tumor cells and how to
translate cell therapies into practice, we’re applying this
knowledge to deliver the first FDA-approved CAR T cell therapy for
multiple myeloma to as many patients as possible. Importantly, we
remain focused on accomplishing our mission by staying genuine and
authentic to our “why” and keeping our people and culture top of
mind every day.
For more information, visit www.2seventybio.com.
Follow 2seventy bio on social media: X (Twitter) and
LinkedIn.
2seventy bio is a trademark of 2seventy bio, Inc.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240829293557/en/
Investors: Vicki Eatwell, CFO
vicki.eatwell@2seventybio.com
Media: Morgan Adams Morgan.adams@2seventybio.com
2seventy bio (NASDAQ:TSVT)
과거 데이터 주식 차트
부터 10월(10) 2024 으로 11월(11) 2024
2seventy bio (NASDAQ:TSVT)
과거 데이터 주식 차트
부터 11월(11) 2023 으로 11월(11) 2024
